Home - Products - Others - Other Targets - [Fmoc-Glu70,Ala71,72,Lys74]-C3a (70-77)

[Fmoc-Glu70,Ala71,72,Lys74]-C3a (70-77)

CAS No. 145082-23-1

[Fmoc-Glu70,Ala71,72,Lys74]-C3a (70-77)( ——— )

Catalog No. M42105 CAS No. 145082-23-1

[Fmoc-Glu70,Ala71,72,Lys74]-C3a (70-77)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Fmoc-Glu70,Ala71,72,Lys74]-C3a (70-77)
  • Note
    Research use only, not for human use.
  • Brief Description
    [Fmoc-Glu70,Ala71,72,Lys74]-C3a (70-77)
  • Description
    [Fmoc-Glu70,Ala71,72,Lys74]-C3a (70-77)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    145082-23-1
  • Formula Weight
    1091.83
  • Molecular Formula
    C53H80N12O13
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AA41612

    AA41612 is a novel antagonist of melanopsin-mediated phototransduction.

  • FIDAS-5

    FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding.?FIDAS-5 has anticancer activities.?FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM.FIDAS-5 induces the expression of cell cycle inhibitor, p21WAF1/CIP1. FIDAS-5 (3 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells.FIDAS-5 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells.

  • PAPTP

    PAPTP